Verified July 2026 · Cited to primary sources
Tesamorelin: Evidence Grade A — FDA-approved / proven in humans.
The honest verdict
Tesamorelin is an FDA-approved drug (Egrifta, 2010) — Grade A, the strongest evidence tier here. But it is approved for HIV-associated visceral fat, not general weight loss; for that, approved GLP-1s are the evidence-backed route.
Tesamorelin at a glance
- Class
- Synthetic GHRH (growth-hormone-releasing hormone) analog
- Mechanism
- A GHRH analog that stimulates the pituitary to release growth hormone, which reduces visceral (abdominal) fat.
- Also known as
- Egrifta, TH9507
- Research applications
- HIV-associated visceral fat reduction (its FDA-approved indication)
- Body recomposition / visceral fat loss (off-label)
- Forms
- subcutaneous injection
- Legal status
- FDA-approved
- WADA (anti-doping)
- Prohibited (S2 — GHRH analog) at all times
- Evidence grade
- Grade AFDA-approved / proven in humans
How we grade evidence
Every grade is assigned by a fixed A–F rubric — human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is Tesamorelin?
One of only two FDA-approved peptides in this space — proven to cut visceral fat, but approved for a narrow HIV indication.
A GHRH analog that stimulates the pituitary to release growth hormone, which reduces visceral (abdominal) fat.
How strong is the evidence for Tesamorelin?
Grade A: FDA-approved (2010) on multiple pivotal Phase 3 RCTs (rule 1 fired — FDA-approved for ≥1 indication). The only currently-marketed FDA-approved GHRH analog.
Primary sources (3)
Is Tesamorelin legal? (Status July 2026)
Prescription via a licensed provider.
What is Tesamorelin used for?
Tesamorelin is marketed for the goals below. See how it ranks against other peptides in each — by evidence, not hype.
What does Tesamorelin cost — and how do you access it legally?
Typical cost
High — branded Egrifta commonly $3,000+/month retail
Branded Egrifta retail is high ($3,000+/month; verify current list price). Compounded tesamorelin is cheaper but variable. Approved indication is HIV-associated visceral fat, not general weight loss.
Legal access routes
Peter MD
telehealth$90–$300 per program (Katalys CPA band)
Marek Health
telehealthMembership + labs; pricing varies by protocol
Hone Health
telehealth$30–$75 per program (Katalys CPA band) + at-home labs
Ways2Well
telehealthProtocol-based pricing; consult required
Some links are affiliate links — we may earn a commission at no cost to you. Access routes are legit telehealth/clinics, never gray-market vendors. How this works.
Trying to lose weight?
For weight loss, an approved GLP-1 beats this peptide.
No research peptide here has proven, legally-available weight-loss data that beats an approved GLP-1. Our sister site compares the options that actually work.
Is Tesamorelinsafe? Side effects & risks
Well-characterized in trials. Glucose intolerance/insulin resistance, injection-site reactions, fluid retention. Contraindicated in active malignancy and pregnancy. WADA-prohibited (S2).
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
Tesamorelin FAQ
Is tesamorelin FDA approved for weight loss?
Tesamorelin is FDA-approved (as Egrifta) to reduce excess visceral abdominal fat in HIV-associated lipodystrophy — not for general weight loss. It genuinely reduces visceral fat in that population (Grade A), but using it for everyday weight loss is off-label. For proven general weight loss, see our GLP-1 guidance.
How much does tesamorelin cost?
Branded Egrifta commonly runs $3,000+ per month at retail. Compounded tesamorelin is cheaper but variable in price and quality. Check current pricing with a licensed provider.
Is tesamorelin banned in sport?
Yes. As a GHRH analog it is on the WADA Prohibited List under S2.
Compare Tesamorelin with…
Head-to-head evidence-grade matchups people weigh against Tesamorelin.
Keep reading
MOTS-c
An "exercise-mimetic" metabolic peptide — real mechanistic interest, but human evidence is association-only.
Grade CCJC-1295 / Ipamorelin
The classic GH-boosting stack — one human PK study shows it raises GH/IGF-1, but no trial shows it builds muscle or burns fat.
Grade CCJC-1295
A GHRH analog — usually the long-acting "with DAC" version — that one human study shows raises GH/IGF-1, but no trial shows it builds muscle or burns fat.
The monthly peptide evidence brief.
What the research and the FDA actually say — one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.